Heterocyclic modified paclitaxel prodrug nanoassemblies for stimuli-responsive delivery via lysosomal escape
Acta Pharmaceutica Sinica B · 2026-03 · 16 (3) · 1662-1675
DOI: 10.1016/j.apsb.2026.01.017 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Pharmaceutica Sinica B, 2026-03. Verfasst von Mingyang Han und 12 weiteren Autor:innen. Beteiligte Einrichtung: Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, China. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Liaoning Revitalization Talents Program, Key Research and Development Program of Liaoning Province, National Key Research and Development Program of China.
Abstract (Originalsprache)
Prodrug nanoassemblies offer an innovative approach to drug delivery, but their lysosomal entrapment often impairs drug release. Notably, tertiary amine structures can undergo protonation reactions, thereby facilitating lysosomal escape through the proton sponge effect. In this study, we developed three novel paclitaxel prodrug nanoassemblies (PTX-SS-NO NPs, PTX-SS-CC NPs and PTX-SS-NC NPs) featuring distinct heterocyclic tertiary amine structures to investigate structure-activity relationships in lysosomal escape and drug delivery. Among them, PTX-SS-NC NPs demonstrated excellent lysosomal escape capability, enabling rapid drug release into the cytosol. Systematic evaluation revealed that the PTX-SS-NC NPs exhibited optimized pharmacokinetics and significant tumor accumulation, further contributing to their strong antitumor efficacy. Our findings establish heterocyclic tertiary amines as crucial design elements for overcoming lysosomal entrapment and optimizing chemotherapeutic prodrug nanoassemblies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, China.
- Department of Pharmacy, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou 121000, China.
- Joint International Research Laboratory of Intelligent Drug Delivery Systems, Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China.
Förderung
- Liaoning Revitalization Talents Program
- Key Research and Development Program of Liaoning Province
- National Key Research and Development Program of China
Zitieren
APA
Han, M., Xu, H., Yuan, J., Li, W., Zhang, H., Fang, H., Kuang, Z., Yu, Y., Wang, D., Zhao, Z., Luo, C., Sun, B., & Sun, J. (2026). Heterocyclic modified paclitaxel prodrug nanoassemblies for stimuli-responsive delivery via lysosomal escape. Acta Pharmaceutica Sinica B, 16(3), 1662-1675. https://doi.org/10.1016/j.apsb.2026.01.017
Vancouver
Han M, Xu H, Yuan J, Li W, Zhang H, Fang H, et al. Heterocyclic modified paclitaxel prodrug nanoassemblies for stimuli-responsive delivery via lysosomal escape. Acta Pharmaceutica Sinica B. 2026;16(3):1662-1675. doi:10.1016/j.apsb.2026.01.017
BibTeX
@article{Han2026,
author = {Han, Mingyang and Xu, Hezhen and Yuan, Jun and Li, Wenxiao and Zhang, Hao and Fang, Hongkai and Kuang, Zhiyu and Yu, Yuanhao and Wang, Danping and Zhao, Zhenzhen and Luo, Cong and Sun, Bingjun and Sun, Jin},
title = {Heterocyclic modified paclitaxel prodrug nanoassemblies for stimuli-responsive delivery via lysosomal escape},
journal = {Acta Pharmaceutica Sinica B},
year = {2026},
volume = {16},
number = {3},
pages = {1662--1675},
doi = {10.1016/j.apsb.2026.01.017}
}
EUVIMED